Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.623

-12.1%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LiPolymer who wrote (6383)	1/27/2000 9:39:00 AM
From: Bill Wexler	Read Replies (1) of 10293

They did it with Zonagen. In the face of incontrovertible evidence that Phentolamine (a 50 year-old generic medication) did not in no way, shape, or form cause erections - even when injected directly into the penis - a CIBC "analyst" issued numerous false reports urging a "strong buy" of Zonagen shares based on ludicrous prospects for Zonagen's fraudulent oral medication for Erectile Dysfunction...a medication whose sole active ingredient was Phentolamine. Even though these reports stressed Zonagen's patents for their pill formulation and 9-figure revenue projections, not once did they mention that even Zonagen's own clinical studies demonstrated the pill was no better than placebo. Based one these reports, I figure small investors got taken to the cleaners to the tune of roughly $300 million. Valence's fraudulent battery technology and unethical management will eventually be its undoing as well.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next